Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient.
about
Present and future pharmacotherapeutic agents in heart failure: an evolving paradigmPrevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the U.S..Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans.
P2860
Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@en
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@nl
type
label
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@en
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@nl
prefLabel
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@en
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@nl
P1476
Pathophysiologic and pharmacot ...... he black hypertensive patient.
@en
P2093
P304
P356
10.1016/0002-8703(88)90102-0
P407
P433
P577
1988-07-01T00:00:00Z